Elevance Health Inc. (ANTM) Stock Competitors & Peer Comparison
See (ANTM) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Plans Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ANTM | $482.58 | +2.71% | 114.6B | 18.99 | $25.41 | +1.42% |
| UNH | $415.63 | -1.00% | 377.3B | 25.42 | $16.34 | +2.16% |
| CVS | $103.45 | -0.13% | 132B | 14.63 | $7.07 | +2.55% |
| ELV | $386.73 | -0.34% | 84B | 12.56 | $30.78 | +1.77% |
| CI | $275.68 | -1.10% | 72.9B | 8.92 | $30.90 | +2.21% |
| HUM | $397.22 | +2.14% | 47.7B | 25.04 | $15.86 | +0.90% |
| CNC | $64.19 | -0.54% | 31.7B | 25.47 | $2.52 | N/A |
| MOH | $228.70 | -0.37% | 11.9B | 32.94 | $6.92 | N/A |
| OSCR | $28.52 | -3.16% | 7.4B | -48.36 | -$0.59 | N/A |
| ALHC | $23.81 | +2.36% | 4.9B | 264.56 | $0.09 | N/A |
Stock Comparison
ANTM vs UNH Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, UNH has a market cap of 377.3B. Regarding current trading prices, ANTM is priced at $482.58, while UNH trades at $415.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas UNH's P/E ratio is 25.42. In terms of profitability, ANTM's ROE is +0.12%, compared to UNH's ROE of +0.12%. Regarding short-term risk, ANTM is more volatile compared to UNH. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check UNH's competition here
ANTM vs CVS Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, CVS has a market cap of 132B. Regarding current trading prices, ANTM is priced at $482.58, while CVS trades at $103.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas CVS's P/E ratio is 14.63. In terms of profitability, ANTM's ROE is +0.12%, compared to CVS's ROE of +0.04%. Regarding short-term risk, ANTM is more volatile compared to CVS. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check CVS's competition here
ANTM vs ELV Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, ELV has a market cap of 84B. Regarding current trading prices, ANTM is priced at $482.58, while ELV trades at $386.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas ELV's P/E ratio is 12.56. In terms of profitability, ANTM's ROE is +0.12%, compared to ELV's ROE of +0.12%. Regarding short-term risk, ANTM is more volatile compared to ELV. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check ELV's competition here
ANTM vs CI Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, CI has a market cap of 72.9B. Regarding current trading prices, ANTM is priced at $482.58, while CI trades at $275.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas CI's P/E ratio is 8.92. In terms of profitability, ANTM's ROE is +0.12%, compared to CI's ROE of +0.15%. Regarding short-term risk, ANTM is more volatile compared to CI. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check CI's competition here
ANTM vs HUM Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, HUM has a market cap of 47.7B. Regarding current trading prices, ANTM is priced at $482.58, while HUM trades at $397.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas HUM's P/E ratio is 25.04. In terms of profitability, ANTM's ROE is +0.12%, compared to HUM's ROE of +0.06%. Regarding short-term risk, ANTM is more volatile compared to HUM. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check HUM's competition here
ANTM vs CNC Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, CNC has a market cap of 31.7B. Regarding current trading prices, ANTM is priced at $482.58, while CNC trades at $64.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas CNC's P/E ratio is 25.47. In terms of profitability, ANTM's ROE is +0.12%, compared to CNC's ROE of -0.29%. Regarding short-term risk, ANTM is more volatile compared to CNC. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check CNC's competition here
ANTM vs MOH Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, MOH has a market cap of 11.9B. Regarding current trading prices, ANTM is priced at $482.58, while MOH trades at $228.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas MOH's P/E ratio is 32.94. In terms of profitability, ANTM's ROE is +0.12%, compared to MOH's ROE of +0.04%. Regarding short-term risk, ANTM is more volatile compared to MOH. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check MOH's competition here
ANTM vs OSCR Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, OSCR has a market cap of 7.4B. Regarding current trading prices, ANTM is priced at $482.58, while OSCR trades at $28.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas OSCR's P/E ratio is -48.36. In terms of profitability, ANTM's ROE is +0.12%, compared to OSCR's ROE of -0.03%. Regarding short-term risk, ANTM is less volatile compared to OSCR. This indicates potentially lower risk in terms of short-term price fluctuations for ANTM.Check OSCR's competition here
ANTM vs ALHC Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, ALHC has a market cap of 4.9B. Regarding current trading prices, ANTM is priced at $482.58, while ALHC trades at $23.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas ALHC's P/E ratio is 264.56. In terms of profitability, ANTM's ROE is +0.12%, compared to ALHC's ROE of +0.11%. Regarding short-term risk, ANTM is more volatile compared to ALHC. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check ALHC's competition here
ANTM vs CLOV Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, CLOV has a market cap of 2.7B. Regarding current trading prices, ANTM is priced at $482.58, while CLOV trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas CLOV's P/E ratio is -43.67. In terms of profitability, ANTM's ROE is +0.12%, compared to CLOV's ROE of -0.17%. Regarding short-term risk, ANTM is more volatile compared to CLOV. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check CLOV's competition here
ANTM vs BHG Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, BHG has a market cap of 130.5M. Regarding current trading prices, ANTM is priced at $482.58, while BHG trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas BHG's P/E ratio is -0.12. In terms of profitability, ANTM's ROE is +0.12%, compared to BHG's ROE of -0.70%. Regarding short-term risk, ANTM is less volatile compared to BHG. This indicates potentially lower risk in terms of short-term price fluctuations for ANTM.Check BHG's competition here
ANTM vs CABR Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, CABR has a market cap of 18.6M. Regarding current trading prices, ANTM is priced at $482.58, while CABR trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas CABR's P/E ratio is -2.17. In terms of profitability, ANTM's ROE is +0.12%, compared to CABR's ROE of -3.00%. Regarding short-term risk, ANTM is less volatile compared to CABR. This indicates potentially lower risk in terms of short-term price fluctuations for ANTM.Check CABR's competition here
ANTM vs BMGL Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, BMGL has a market cap of 10.5M. Regarding current trading prices, ANTM is priced at $482.58, while BMGL trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas BMGL's P/E ratio is -1.26. In terms of profitability, ANTM's ROE is +0.12%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, ANTM is less volatile compared to BMGL. This indicates potentially lower risk in terms of short-term price fluctuations for ANTM.Check BMGL's competition here
ANTM vs UAM Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, UAM has a market cap of 0. Regarding current trading prices, ANTM is priced at $482.58, while UAM trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas UAM's P/E ratio is 1.01. In terms of profitability, ANTM's ROE is +0.12%, compared to UAM's ROE of +0.17%. Regarding short-term risk, ANTM is more volatile compared to UAM. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check UAM's competition here
ANTM vs AET Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, AET has a market cap of 0. Regarding current trading prices, ANTM is priced at $482.58, while AET trades at $106.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas AET's P/E ratio is 9.57. In terms of profitability, ANTM's ROE is +0.12%, compared to AET's ROE of +0.11%. Regarding short-term risk, ANTM is more volatile compared to AET. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check AET's competition here
ANTM vs GTS Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, GTS has a market cap of 0. Regarding current trading prices, ANTM is priced at $482.58, while GTS trades at $35.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas GTS's P/E ratio is 10.41. In terms of profitability, ANTM's ROE is +0.12%, compared to GTS's ROE of +0.07%. Regarding short-term risk, ANTM is more volatile compared to GTS. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check GTS's competition here
ANTM vs MGLN Comparison July 2026
ANTM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ANTM stands at 114.6B. In comparison, MGLN has a market cap of 0. Regarding current trading prices, ANTM is priced at $482.58, while MGLN trades at $94.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ANTM currently has a P/E ratio of 18.99, whereas MGLN's P/E ratio is 8.49. In terms of profitability, ANTM's ROE is +0.12%, compared to MGLN's ROE of +0.00%. Regarding short-term risk, ANTM is more volatile compared to MGLN. This indicates potentially higher risk in terms of short-term price fluctuations for ANTM.Check MGLN's competition here